Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Lantheus stock

Learn how to easily invest in Lantheus stock.

Lantheus Holdings Inc
NASDAQ: LNTH - USD
$26.24
- $1.05 ( - 3.85%)
DIAGNOSTICS & RESEARCH

Lantheus Holdings Inc is a diagnostics & research business based in the US. Lantheus shares (LNTH) are listed on the NASDAQ and all prices are listed in US Dollars. Lantheus employs 595 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Lantheus

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – LNTH – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Lantheus stock price (NASDAQ: LNTH)

Use our graph to track the performance of LNTH stocks over time.

Lantheus shares at a glance

Information last updated 2022-01-17.
Latest market close$27.29
52-week range$15.20 - $31.60
50-day moving average $28.16
200-day moving average $25.37
Wall St. target price$36.33
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.51

Buy Lantheus shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
TradeStation
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
$10 of crypto
Open an account with access to crypto
A platform built for all kinds of traders and all styles of trading
SoFi Invest
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in most equities.
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Moomoo
Stocks, Options, ETFs
$0
$0 per year
Get a free stock valued up to $3500
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
0%
$125 - $625
Open and fund an account with $25,000 - $250,000+
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Lantheus stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Lantheus price performance over time

Historical closes compared with the close of $27.29 from 2022-01-14

1 week (2022-01-12) 1.15%
1 month (2021-12-17) 0.55%
3 months (2021-10-19) 17.88%
6 months (2021-07-19) 7.06%
1 year (2021-01-19) 74.94%
2 years (2020-01-17) 44.28%
3 years (2019-01-18) 64.70%
5 years (2017-01-18) 195.03%

Is Lantheus stock undervalued or overvalued?

Valuing Lantheus stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Lantheus's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Lantheus's PEG ratio

Lantheus's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.61. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Lantheus's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Lantheus's EBITDA

Lantheus's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $40.8 million.

The EBITDA is a measure of a Lantheus's overall financial performance and is widely used to measure a its profitability.

Lantheus financials

Revenue TTM $389.8 million
Operating margin TTM 0.64%
Gross profit TTM $146.1 million
Return on assets TTM 0.18%
Return on equity TTM -6.81%
Profit margin -8.85%
Book value $7.38
Market capitalisation $1.8 billion

TTM: trailing 12 months

Lantheus share dividends

We're not expecting Lantheus to pay a dividend over the next 12 months.

Lantheus share price volatility

Over the last 12 months, Lantheus's shares have ranged in value from as little as $15.2 up to $31.6. A popular way to gauge a stock's volatility is its "beta".

LNTH.US volatility(beta: 1.31)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Lantheus's is 1.3077. This would suggest that Lantheus's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Lantheus overview

Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic agents and products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for nuclear medicine; Xenon-133 to assess pulmonary function; Neurolite to identify the area within the brain where blood flow has been blocked or reduced due to stroke; Cardiolite, an injectable Tc-99m-labeled imaging agent; and RELISTOR for opioid-induced constipation. The company also offers AZEDRA, a radiotherapeutic to treat adult and pediatric patients; Automated Bone Scan Index that calculates the disease burden of prostate cancer by quantifying the hotspots on bone scans; and Cobalt (Co 57), a non-pharmaceutical radiochemical. It provides Thallium-201 to detect cardiovascular disease; Gallium-67 to detect various infections and cancerous tumors; and Quadramet for severe bone pain associated with osteoblastic metastatic bone lesions. The company also develops PyL for prostate cancer; flurpiridaz F 18 to assess blood flow to the heart; 1095, a PSMA-targeted iodine-131 labeled small molecule; LMI 1195 for neuroendocrine tumors; PSMA TTC, a thorium-227 labeled PSMA-targeted antibody therapeutic; 1404, a Tc-99m labeled small molecule; PSMA-AI, an AI-based imaging analysis technology; and leronlimab, an investigational humanized monoclonal antibody. It serves radiopharmacies, PET manufacturing facilities, integrated delivery networks, hospitals, clinics, and group practices.

Frequently asked questions

What percentage of Lantheus is owned by insiders or institutions?
Currently 2.583% of Lantheus shares are held by insiders and 95.374% by institutions.
How many people work for Lantheus?
Latest data suggests 595 work at Lantheus.
When does the fiscal year end for Lantheus?
Lantheus's fiscal year ends in December.
Where is Lantheus based?
Lantheus's address is: 331 Treble Cove Road, North Billerica, MA, United States, 01862
What is Lantheus's ISIN number?
Lantheus's international securities identification number is: US5165441032
What is Lantheus's CUSIP number?
Lantheus's Committee on Uniform Securities Identification Procedures number is: 516544103

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site